Amit Hasija

Amit Hasija discloses dealings in Milestone Pharmaceuticals Inc. to SEC (Form 4). In total, 5 filings cover trades dated from 11 July 2025 to 26 January 2026.

On the market, this insider has only sold: 2 sales, €135k in total. Besides market trades, the filings include 2 share grants and 1 option exercise. Since January 2026: no purchases and 2 sales on the market.

On 28 January 2026 came the latest disclosure, an option exercise in Milestone Pharmaceuticals Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 4 days. Section 16 rules allow two business days to file each Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.